Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levels

Effect of clinical decision support for severe hypercholesterolemia on low-density lipoprotein cholesterol levels

Abstract Severe hypercholesterolemia/possible familial hypercholesterolemia (FH) is relatively common but underdiagnosed and undertreated. We investigated whether implementing clinical decision support (CDS) was associated with lower low-density lipoprotein cholesterol (LDL-C) in patients with sever...

Full description

Bibliographic Details
Main Authors:	Hana Bangash, Seyedmohammad Saadatagah, Mohammadreza Naderian, Marwan E. Hamed, Lubna Alhalabi, Alborz Sherafati, Joseph Sutton, Omar Elsekaily, Ali Mir, Justin H. Gundelach, Daniel Gibbons, Paul Johnsen, Christina M. Wood-Wentz, Carin Y. Smith, Pedro J. Caraballo, Kent R. Bailey, Iftikhar J. Kullo
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-03-01
Series:	npj Digital Medicine
Online Access:	https://doi.org/10.1038/s41746-024-01069-w

Similar Items

Clinician Perspectives on Clinical Decision Support for Familial Hypercholesterolemia
by: Hana Bangash, et al.
Published: (2023-05-01)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
by: Seyedmohammad Saadatagah, et al.
Published: (2022-12-01)

Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population‐Based Study
by: Seyedmohammad Saadatagah, et al.
Published: (2021-06-01)

An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia
by: Hana Bangash, et al.
Published: (2020-07-01)

Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
by: Hana Bangash, et al.
Published: (2022-02-01)

Design of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
by: Iftikhar J. Kullo, et al.
Published: (2018-08-01)

Lipoprotein(a) in Familial Hypercholesterolemia
by: Erin O. Jacob, BMSc, et al.
Published: (2024-01-01)

Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia
by: Medhat Farwati, et al.
Published: (2018-11-01)

Implementation Science to Increase Adoption of Genomic Medicine: An Urgent Need
by: Hana Bangash, et al.
Published: (2020-12-01)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
by: Uliana V. Chubykina, et al.
Published: (2022-01-01)

Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
by: Elena Olmastroni, et al.
Published: (2023-05-01)

Lipoprotein-X: A Case of Falsely Elevated LDL Hypercholesterolemia
by: Jacob Y. Mok, MD, et al.
Published: (2023-05-01)

Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia
by: Ewelina Woźniak, et al.
Published: (2024-01-01)

Familial Hypercholesterolemia and Lipoprotein(a): A Gordian Knot in Cardiovascular Prevention
by: Amalia Despoina Koutsogianni, et al.
Published: (2022-11-01)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
by: Hayato Tada, et al.
Published: (2022-12-01)

Severe Hypercholesterolemia Mediated by Lipoprotein X in an Immunosuppressed Patient: A Case Report
by: Cristiana Sequeira, et al.
Published: (2022-10-01)

Pregnancy in a Woman with Homozygous Familial Hypercholesterolemia Not on Low-Density Lipoprotein Apheresis
by: Akl C. Fahed, et al.
Published: (2012-11-01)

Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein
by: Ewa Wieczorek, et al.
Published: (2021-04-01)

Epidemiology of atherosclerotic cardiovascular disease in polygenic hypercholesterolemia with or without high lipoprotein(a) levels
by: Pierandrea Vinci, et al.
Published: (2024-01-01)

Hypercholesterolemia After COVID-19: Time to Include Lipoprotein X Among the Differential Diagnoses
by: Jennifer Girard, MD, et al.
Published: (2023-03-01)

Physiologically-regulated low density lipoprotein receptor (LDLR) expression vectors for the treatment of familial hypercholesterolemia
by: Hibbitt, O, et al.
Published: (2008)

Low-density lipoprotein receptor genotypes modify the sera metabolome of patients with homozygous familial hypercholesterolemia
by: Zhiyong Du, et al.
Published: (2022-11-01)

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels
by: Sayaka Funabashi, et al.
Published: (2022-08-01)

The Effect of Melinjo Peel Extract in Activity of Lipoprotein Lipase Enzym of The Rats Fed a Hypercholesterolemia Diet
by: Athira Demitri
Published: (2018-12-01)

J wave syndrome: Benign or malignant?
by: Alborz Sherafati, et al.
Published: (2021-08-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
by: V. B. Vasilyev, et al.
Published: (2022-06-01)

Increased Circulating Levels of PCSK9 and Pro-Atherogenic Lipoprotein Profile in Pregnant Women with Maternal Supraphysiological Hypercholesterolemia
by: Claudette Cantin, et al.
Published: (2022-04-01)

Familial hypercholesterolemia in St.-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia
by: Konstantinov Vladimir O, et al.
Published: (2005-02-01)

Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a)
by: Andrea Schwarz, et al.
Published: (2022-11-01)

Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase.
by: Fisher, R, et al.
Published: (1995)

Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
by: Lilla Juhász, et al.
Published: (2023-10-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

Monozygotic twins with familial hypercholesterolemia and high lipoprotein(a) levels leading to identical cardiovascular outcomes: Case report and review of the literature
by: Meral Kayıkçıoğlu, et al.
Published: (2020-07-01)

Familial hypercholesterolemia
by: J.P.S. Sawhney, et al.
Published: (2024-03-01)

Familial Hypercholesterolemia
by: FENG Siqin, et al.
Published: (2023-01-01)

Hereditary chromosomal 9 inversion (p22q13) 9 as a cause for recurrent pregnancy loss: a case report
by: Mohammad Marwan Alhalabi, et al.
Published: (2023-10-01)

A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia.
by: Björn Lundahl, et al.
Published: (2000)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
by: Isabella Ramos Lima, et al.
Published: (2022-08-01)

Addressing comprehensive complexities a striking familial hypercholesterolemia case study
by: Shazia Rasheed, et al.
Published: (2024-04-01)